C-Peptide

N/A

Report date: 2024/08/08 17:09:58
NME

Base Information

Drug NameC-Peptide
Drug Alias NameSPM-933
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionNitric oxide synthase stimulantsATPase inhibitors
TargetsNitric oxide synthaseATPase
Therapy Area/IndicationsDiabetic peripheral neuropathyHypoglycemiaDiabetes Mellitus, Type 1 +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSweden
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCebix Incorporated
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Cincinnati
Active IndicationsHypoglycemiaDiabetes Mellitus, Type 1
Inactive IndicationsDiabetic peripheral neuropathyDiabetes MellitusDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG